| T1080 |
2-Aminoethanethiol
|
60-23-1
|
98%
|
|
|
2-Aminoethanethiol (Cysteamine) is a Cystine Depleting Agent. The mechanism of action of cysteamine is as a Cystine Disulfide Reduction.
|
| T2584 |
Octreotide
|
83150-76-9
|
98%
|
|
|
Octreotide (SMS 201-995) is a potent inhibitor of growth hormone, glucagon, and insulin.
|
| T7829 |
FK962
|
283167-06-6
|
98%
|
|
|
FK962 is an somatostatin release enhancer , exerts cognitive-enhancing actions.
|
| T11800 |
L-803087
|
217480-26-7
|
98%
|
|
|
L-803087 is a potent and selective agonist of the growth inhibitor sst4 receptor with a Ki value of 0.7 nM for sst4, which is more than 280-fold more selective t...
|
| T9692 |
Paltusotine
|
2172870-89-0
|
98%
|
|
|
Paltusotine is a nonpeptide, small molecule somatostatin type 2 (SST2) receptor agonist with high oral bioavailability. Paltusotine maintains GH and IGF-1 levels...
|
| TP2124L |
Somatostatin 1-28 acetate
|
|
98%
|
|
|
Somatostatin 1-28 acetate circulates in human plasma. Approximately 46% of the total somatostatin-like immunoreactivity in plasma is due to Somatostatin 1-28 ace...
|
| T32511 |
L-796,778
|
217480-25-6
|
98%
|
|
|
L-796,778 is an SST3 agonist and a selective ligand of SST3, which can increase the level of cAMP in the body.
|
| TP1188L |
Cortistatin 14, human, rat acetate
|
TP1188L
|
97.86%
|
|
|
Cortistatin 14, human, rat acetate is a neuropeptide having structural similarity to somatostatin-14 and shows anticonvulsive, neuroprotective effects and remark...
|
| TP1570L |
Cortistatin-14 acetate
|
|
98.24%
|
|
|
Cortistatin-14 acetate, a neuropeptide have structural similarity to somatostatin-14, binds and exerts its function via the somatostatin receptors (sst1-sst5). C...
|
| T21567L |
Cyclosomatostatin Acetate
|
T21567L
|
98.83%
|
|
|
Cyclosomatostatin Acetate is an effective antagonist of the somatostatin receptor.Cyclosomatostatin Acetate inhibits SSTR1 signaling and decreases cell prolifera...
|
| T28743 |
Seglitide acetate
|
99248-33-6
|
98.87%
|
|
|
Seglitide acetate (MK-678) is a selective agonist of sst2 somatostatin receptor.
|
| T77670 |
(1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid
|
2919211-45-1
|
99.23%
|
|
|
(1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid is a potential SSTR4 agonist.
|
| T4119 |
Octreotide Acetate
|
79517-01-4
|
99.57%
|
|
|
Octreotide Acetate (Sandostatin) is a potent, long-acting synthetic somatostatin octapeptide analog that inhibits secretion of growth hormone.
|
| TP1346 |
CYN 154806 TFA
|
2828432-46-6
|
99.7%
|
|
|
CYN 154806 TFA is a cyclic octapeptide and an effective selective somatostatin sst2 receptor antagonist. For the recombinant sst2, sst1, sst3, sst4 and sst5 rece...
|
| T39262L |
BIM-23190 aceate
|
|
99.7%
|
|
|
BIM-23190 aceate, a somatostatin analog, a selective agonist of SSTR2 and SSTR5. BIM-23190 can be used in cancer and acromegaly studies.
|
| TP2207 |
Pasireotide Acetate
|
396091-76-2
|
99.92%
|
|
|
Pasireotide Acetate is a stable cyclohexapeptide somatostatin mimic
|
| T32511L |
L-796,778 acetate
|
|
98%
|
|
|
L-796,778 acetate is a slective somatostatin receptor agonist with IC50 of 24nM for sst3, for sst1, sst2, sst4 and sst5, IC50 is >1000nM.
|
